Featured Research

from universities, journals, and other organizations

Cure for HIV is a 'major scientific priority'

Date:
June 24, 2014
Source:
Monash University
Summary:
Huge advancements have taken place in HIV treatment and prevention over the past 10 years, but there is still no cure or vaccine. A new review shows that because of advancements in treatment, people with the virus are living longer. Overall, new infections have decreased from 3.3 million in 2002 to 2.3 million in 2012. Global AIDS-related deaths peaked at 2.3 million in 2005, decreasing to 1.6 million by 2012.

Huge advancements have taken place in HIV treatment and prevention over the past 10 years, but there is still no cure or vaccine.

The findings are part of a review into the global HIV epidemic published in The Lancet, co-authored by Monash University Professor Sharon Lewin.

The review shows that because of advancements in treatment, people with the virus are living longer. Overall, new infections have decreased from 3.3 million in 2002 to 2.3 million in 2012. Global AIDS-related deaths peaked at 2.3 million in 2005, decreasing to 1.6 million by 2012.

Professor Lewin, Head of the Department of Infectious Diseases at the University, said in the past decade there had been huge advancements in ways to prevent HIV that don't rely on changes in behaviour alone -- for example clean needles and condom use.

"These 'biomedical prevention' strategies have had a major impact in reducing the number of new infections," Professor Lewin said.

"One of the most important advances has been that treating an HIV-infected person with anti-HIV drugs dramatically reduces their infectiousness. Therefore, with more people on effective treatment, we are seeing less transmission."

While an effective vaccine still remains elusive, a number of new approaches are being undertaken to find one. Unlike most infections or diseases, when it comes to HIV many people create ineffective antibodies.

"However, a small number of people make very good antibody responses to HIV -- what is called 'broadly neutralizing antibodies'," Professor Lewin said.

"These 'broadly neutralizing antibodies' are very effective at combating a wide range of strains of HIV. We now have very smart ways to make these antibodies using test tube models, which gives hope for new effective vaccines against HIV."

Professor Lewin said treatment against HIV was highly effective but needed to be life-long as there was no cure for the virus.

"A cure for HIV is now considered to be a major scientific priority," Professor Lewin said.

"We now have a very good understanding of why current treatments don't cure HIV. This is because the virus manages to get into a cell, become part of the patient's DNA and remain silent.

"There is a lot of work being done, including in the Department of Infectious Diseases at Monash, using new ways to 'wake up' the sleeping virus to make it visible to drugs and the immune system. This is one approach that one day might lead to a cure," Professor Lewin said.


Story Source:

The above story is based on materials provided by Monash University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Gary Maartens, Connie Celum, Sharon R Lewin. HIV infection: epidemiology, pathogenesis, treatment, and prevention. The Lancet, 2014; DOI: 10.1016/S0140-6736(14)60164-1

Cite This Page:

Monash University. "Cure for HIV is a 'major scientific priority'." ScienceDaily. ScienceDaily, 24 June 2014. <www.sciencedaily.com/releases/2014/06/140624093330.htm>.
Monash University. (2014, June 24). Cure for HIV is a 'major scientific priority'. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2014/06/140624093330.htm
Monash University. "Cure for HIV is a 'major scientific priority'." ScienceDaily. www.sciencedaily.com/releases/2014/06/140624093330.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins